DelveInsight launched a new report on Infliximab Biosimilar Insights 2020.
DelveInsight’s, “Infliximab Biosimilar Insight, 2020,” report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in the Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Behçet’s disease.
Request for a detailed sample copy of the report: https://www.delveinsight.com/sample-request/infliximab-biosimilars-insight
Infliximab Marketed Drugs:
1. Inflectra: Celltrion/Pfizer
2. Renflexis: Merck
Infliximab Emerging Drugs:
1. BCD 055: Biocad
2. CT-P17: Celltrion
Pipeline Development Activities
The report covers detailed information on collaborations, acquisition, and merger, licensing along a thorough therapeutic assessment of emerging Infliximab biosimilar drugs.
Table of contents:
1. Key Insights
2. Infliximab Biosimilars: Snapshot
3. Executive Summary
4. Regulatory Outlook For Biosimilars
5. Infliximab (Reference Product: Remicade)
6. Research and Development
7. Remicade Biosimilar: Emerging Opportunities
8. Infliximab: Biosimilars Assessment
9. Infliximab Biosimilars Profiles: By Company
10. Infliximab Biosimilars: Comparative Landscape: By Company
11. Infliximab Biosimilars: Competitive Landscape
12. Market Drivers
13. Market Barriers
14. SWOT Analysis
17. DelveInsight Capabilities
19. About DelveInsight
Download free report: https://www.delveinsight.com/report-store/infliximab-biosimilars-insight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States